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Coincident with trends in other areas of biologic research,
there has been a growing interest by investigative nephrologists
in the use of tissue culture techniques. This interest has been
stimulated by an increasing awareness of the large amount of
biologic information gained from the use of this technique in
other cellular systems. Renal cell culture has assumed a posi-
tion of methodologic significance equivalent to any of the more
traditional techniques applied to the study of the kidney. The
accumulation of a critical mass of research experience by a
small number of early investigators [1—51, coupled with the
ready availability of commercial preparations designed to facil-
itate tissue culture, have led to a rapid increase in the number of
investigators who employ glomerular cell culture in their re-
search programs. The relevant literature now encompassses
several hundred publications, and has been the subject of
several recent comprehensive reviews [6—91. In this paper a
resummation of this literature will not he attempted. Rather, we
wish to focus on the use of cell culture as a technique to be used
in conjunction with other analytic methods for the study of
inflammatory glomerular reactions, as represented by im-
mune—mediated glomerulonephritis or other glomerular lesions
characterized by cellular proliferation and matrix expansion.
Indeed, the present issue is not whether, or how, one can grow
defined populations of glomerular cells, but rather to utilize cell
culture as a means to identify the distinctive biologic properties
of glomerular cells relevant to the glomerular inflammatory
process.
Inflammation is the response of vascularized tissue to injury.
Basically, the inflammatory response promotes repair and heal-
ing of the initial lesion. In doing so, the inflammatory process
may transiently or permanently interfere with normal tissue
function [101. As the glomerular ultrafiltration apparatus is an
intricate part of the renal vasculature, the glomerular capillaries
are constantly and directly exposed to injurious stimuli derived
from the circulation. Their nature may be toxic, metabolic or
immunologic. Moreover, microbial agents as well as intraglo-
merular hypertension may cause injury to glomerular cells and
initiate an inflammatory reaction. In the past, the responses of
glomerular cells to injury have been characterized solely on the
structural level, as defined by conventional light microscopy.
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Such methods have shown that the predominant reactions of
the glomerular cells to injury are proliferation and expansion of
the extracellular matrix. In addition, potential interactions of
the intrinsic glomerular cells with infiltrating inflammatory cells
were indicated by the presence of polymorphonuclear leuko-
cytes, monocyte—macrophages, lymphocytes and platelets
within inflamed glomeruli [11, 121. There is as yet little infor-
mation as to the etiologic factors or pathogenetic mechanisms
which induce these glomerular structural alterations. Work with
defined populations of glomerular cells under controlled culture
conditions allows one to study the nature of the glomerular
inflammatory process in a more directed and specific manner
than is possible in vivo. In this paper we will discuss the uses of
glomerular cell culture which relate to the following major
aspects of glomerular inflammation:
1. Determinants of cellular proliferation;
2. Factors controlling production and degradation of extra-
cellular matrix;
3. Ability of glomerular cells to secrete biologically active
substances;
4. Glomerular cell reactions to specific inflammatory media-
tors.
Cell culture: Problematic areas
Before addressing each of the above issues, several proble-
matic aspects of glomerular cell culture should be considered.
The glomerulus consists of at least four major cell types
(epithelial, endothelial, contractile mesangial, bone mar-
row—derived mesangial). In the past, procurement of well
characterized, homogeneous populations of cultured cells has
proven difficult. Harpcr, et al [13], and Striker and Striker 191,
have recently provided detailed methods for glomerular cell
culture, as well as comprehensive profiles of individual cellular
characteristics which should help to resolve this difficulty. In
addition to these fundamental problems of purity and cellular
characterization, several other aspects deserve consideration.
In the normal adult, the intrinsic glomerular cells have very low
replicative rates [14, 151. In contrast, the initiation of cell
culture necessitates active and prolonged cellular proliferation.
While it is obvious that the induction of cellular proliferation is
a sine qua non for cell culture, this transition to a rapidly
proliferating state is associated with the loss of many differen-
tiated cellular features. Additionally, cultured cells may acquire
new phenotypic characteristics not seen in vivo. For example,
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cultured glomerular epithelial cells lose their highly differenti-
ated podocytic structure, and assume a flattened, polygonal
morphology with occasional cilia [5, 13]. Similarly, vascular
smooth muscle cells rapidly lose their highly differentiated
cytoskeletal structure in culture [16, 17].
Under normal conditions in vivo, the glomerular cells are
exposed only to autologous plasma or plasma ultrafiltrate. This
condition contrasts significantly with that in vitro, in which cells
are cultured in the presence of nonautologous serum. Serum
represents in essence a pathologic fluid, containing the products
of platelet and coagulation system activation not present in
plasma. Objectively considered then, the behavioral responses
of cells cultured with serum are more reflective of an abnormal
condition, and may actually resemble the state of glomerular
injury in vivo. In addition to serum, peptide growth factors and
conditioned media from various cell lines have been used to
stimulate cellular growth IS, 13, 18]. Given that a primary goal
of tissue culture is to obtain sufficient cellular material for
study, the very use of these complex mixtures may have
profound influence upon the resultant cellular phenotypes.
More recent efforts to provide chemically defined media con-
taining minimal amounts of serum may help to resolve this issue
[13, 19, 20].
Glomerular cells, in particular rat mesangial cells, have been
most often cultured on plastic; the use of collagen or fibronectin
coatings appears to facilitate the adherence and growth of
visceral epithelial cells [13]. The composition of the extracellu-
tar matrix has been shown in many cellular systems to exert
major effects upon the phenotypic properties of cultured cells
[21]. Extracellular matrix may modulate proliferative compe-
tence or the cellular response to exogenously provided growth
factors [22]. Furthermore, several critical growth tctors, such
as fibroblast growth factor, have been shown to adhere to the
extraceltular matrix [231, thereby altering growth characteris-
tics. The presently utilized substrates have been selected for
their adherence and growth potentiating properties. However,
one should be aware that the biochemical composition of these
matrices is quite different from that present within the normal
glomerulus. Thus, in considering the various biologic activities
of cultured glomerular cells, attention must be given to the
modulatory influences of the substratum upon which the cells
are cultivated.
Following the establishment of cell culture, the influence of
growth status and passage number requires consideration. For
example, vascular smooth muscle cells, a cell type closely
resembling the contractile mesangial cell, demonstrate signifi-
cant changes in secretory phenotype and growth characteristics
which are directly dependent upon the degree of cellular
confluency [171. To date, little attention has been given in the
glomerular cell culture literature to the issue of early vs. late
passage cells. This is a significant variable, as late passage
cultures consist primarily of cells which have been selectively
adapted to the conditions of prolonged culture under the
pressure of serum mitogens, and which may no longer he
representative of the cell type of origin. Finally, the age of the
donor animal should be taken into account. Glomerular cells
from young animals or infant kidneys have been found to grow
significantly better than those obtained from adult animals
[24—26]. This improved growth facility may be related in part to
an age—dependent change in the release of autogrowth factors
by the cultured cells. Seifert, Schwartz and Bowen—Pope [27]
have demonstrated an age—dependent change in the release of a
platelet—derived growth factor—like molecule from cultured rat
vascular smooth muscle cells. Others have found an age—de-
pendent decrease in the ability of cultured vascular smooth
muscle cells to secrete prostacyclin [281. While it may be easier
to initiate cultures from very young animals, the potential
influence of donor age upon the phenotypic properties of the
glomerular cells should not he overlooked and, in fact, repre-
sents an area of potential investigation.
Cellular proliferation
Hypercellularity is a common feature of many forms of
glomerular inflammation. While early studies emphasized the
role of infiltrating inflammatory cells as the source of the
increase in cell number, it is now evident that hypercellularity is
also due to an enhanced proliferation of the intrinsic glomerular
cell population [29—341. Culture techniques have helped to
clarify the proliferative responses of these cells to a number of
growth stimuli. Much of this work has involved cultured
glomerular mesangial cells [35—401. It is to be expected that with
the present ability to satisfactorily culture epithelial and
endothelial cells, the individual proliferative control mecha-
nisms of these cell types will be clarified.
The quantitation of cellular proliferation rates has been most
commonly performed by either direct cell counting of trypsin-
ized cultures or by measurement of 3H-thymidine incorporation
into newly synthesized DNA. The second method is sensitive
and provides very reproducible assessment of DNA synthesis.
This assay may be most conveniently performed by culturing
cells in microtiter wells. At given time intervals, the cells are
pulsed with radiolahelled thymidine for 18 to 24 hours. The
labelled DNA is recovered onto glass fiber filters with an
automatic cell harvester and the amount of 3H-thymidine quan-
titated by liquid scintillation counting. Although more tedious,
autoradiographic analysis may provide additional information
on growth fractions and the cell cycle time [39]. A number of
variables may confound the interpretation of results obtained
by the measure of thymidine uptake by cultured cells. Control
experiments should document that changes in thymidine uptake
directly correlate with changes in cell number obtained by
direct counting. This is particularly important when assessing
the effects of pharmacologic or inflammatory agents which may
affect the transport or phosphorylation of the labelled thymidine
without significantly altering cellular proliferation rates [41—431.
The serial determination of thymidine uptake in response to
various growth stimuli may offer a more complete assessment
of the kinetic processes operative in the cellular response to
such agents. The construction of growth curves allows one to
differentiate between factors which actually stimulate cellular
proliferation vs. those which may prevent the decay in growth
fraction commonly seen with non-transformed cells [44—46].
Utilizing these techniques, it has been possible to decipher
some of the mechanisms which control the mesangial prolifer-
ative response to monocyte products. Several observations [32,
35—37] indicate that monocyte/macrophage supernates contain
mesangial cell growth stimulating activity. Using the 31-l-thy-
midine assay, it was possible to characterize the monocyte—
derived growth stimulatory substance as interleukin 1 [391. The
characterization sequence employed standard protein biochem-
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istry steps, including salt precipitation, molecular sieving and
ion exchange chromatography. Using a similar approach,
Castellot et al [401 have identified a growth inhibitory substance
released by epithelial cells as a heparin—like molecule. These
examples represent only a beginning, as much more needs to be
learned about the proliferative (or growth inhibitory) responses
of glomerular cells to platelets, coagulation cascade compo-
nents, and soluble factors released by infiltrating inflammatory
cells. It is very likely that other growth modulatory factors
remain to be identified. By utilizing relatively simple growth
assays, coupled with standard biochemical separation tech-
niques, one may expect to learn much more in the near future
about the mechanisms determining glomerular cell prolifera-
tion. This information is needed for the design of therapeutic
agents which could modulate or control the proliferative re-
sponse.
Extracellular matrix
Each glomerular cell type either grows upon, or is sur-
rounded by, a complex support structure, or extracellular
matrix. In the case of visceral epithelial and endothelial cells,
this matrix is structurally highly organized and constitutes the
glomerular basement membrane. The normal mesangium con-
tains a small amount of less—organized matrix material. Glomer-
ular matrix structures are composed of varying proportions of
type JV and V collagen, laminin, fibronectin, entactin, and
sulfated glycosoaminoglycans among other less well defined
components [47]. Little is known about the factors which
regulate the synthesis and turnover of the matrix or the control
mechanisms governing its supramolecular structure. The abso-
lute quantity of extracellular matrix represents a dynamic
balance between synthesis and degradation. The functional
properties of the matrix may be altered by compositional
changes without variation in the net quantity. Expansion of the
extracellular matrix compartment is a key feature of prolonged
glomerular inflammatory processes, often leading to sclerosis
and obliteration of glomeruli.
The introduction of glomerular cell culture had permitted a
new approach to the analysis of this central problem of progres-
sive glomerular disease. As a first step, the extracellular matrix
products of particular glomerular cell types have been exam-
ined. It is now known that cultured epithelial cells synthesize
type IV collagen, fibronectin and heparan sulfate proteoglycan
[38, 48—50]. Mesangial cells were shown to secrete types I, III,
IV and V collagens, fibronectin, and varying proportions of
sulfated glycosoaminoglycans [38, 49—51]. Large amounts of
these extracellular matrix constituents accumulate in prolonged
culture of mesangial cells [52]. There is presently no informa-
tion concerning the matrix synthetic profile of glomerular
endothelial cells. While demonstrating what the synthetic
products are, these studies represent only a beginning. The
techniques appropriate to an analysis of regulatory factors
governing matrix synthesis have been well established in other
systems. Profiles of total protein products are conveniently
obtained by biosynthetic labelling with 3S-methionine, fol-
lowed by SDS-PAGE of acid precipitated proteins [53, 54].
Collagen proteins may be more efficiently labelled with 3H-
proline and 3H-glycine, and the specific types identified by
immune precipitation with monospecific antibodies and electro-
phoresis. Enzyme—linked immunoabsorption assays offer a
nonradioactive means of precisely quantifying matrix antigen
production; however, these assays require the preparation of
significant quantities of pure antigen and monospecific antisera.
Sulfated glycosoaminoglycans are commonly analyzed by
biosynthetic labelling with 35S-S04 followed by size fraction-
ation and electrophoresis on cellulose acetate. Specific types
may then be identified by selective digestion with chrondroi-
tinases, by sensitivity to nitrous acid oxidation, or by assays
utilizing monospecific antibodies [49, 55—57]. In all these pro-
cedures, rigorous attention must be given to the inclusion of a
battery otprotease inhibitors. When collagenous proteins are to
be studied the media should be supplemented with ascorbate
and beta—aminoproprionitrile. Furthermore, the proportion of
newly synthesized matrix material which may be incorporated
into the cell layer or released free into the growth medium is
quite variable. Quantitative studies of factors affecting matrix
synthesis must consider both sites. The specificity of changes in
matrix synthetic rates may be assessed by comparison with
total cellular protein synthesis [58]. Studies utilizing radiolabel-
led precursors must also consider the effects of growth modu-
latory agents on precursor pool size and turnover rate [59, 60].
Quantitative analyses of glomerular matrix synthesis which
include such controls are only just beginning.
The net quantity of matrix present is also determined by the
activity of various proteases which can specifically degrade
matrix components. At present, there is much less information
on this aspect of matrix control than is available for the
synthetic profile. Matrix can be degraded by highly specific
neutral proteinases, such as collagenase, as well as by
proteinases with much broader substrate spectra [6 1—641. Many
of these enzymes are secreted into the media, frequently in a
latent form. As a first step in the examination of this issue, it
was found that rat mesangial cells released into the culture
media a latent metalloendopeptidase which was identified using
the nonphysiologic substrate, casein [651. The enzyme was
subsequently found to be capable of degrading purified type IV
and V collagen, as well as the insoluble type IV collagen
contained within intact glomerular basement membrane [65,
661. Classical interstitial collagenase activities against types I
and Ill collagen have to date not been detected in mesangial cell
supernates.
While nonphysiologic substrates, such as casein, are useful in
the screening of culture supernates for the presence of matrix—
degrading proteases, ultimately each of these activities must be
characterized using purified matrix components. Substrate in-
terstitial collagen may be extracted from skins or tendon and
radiolabelled with 3H- or 14C acetic anhydride [67]. Other
substrates may be prepared by similar extraction procedures, or
by biosynthetically labelling the matrices produced by various
tumor cell lines [68, 69]. The purification and characterization
of the matrix—degrading enzymes derived from the intrinsic
glomerular cells will provide much needed information on the
factors controlling the quantity and properties of the glomerular
extracellular matrix.
Biologically active substances
Besides producing matrix constituents and neutral pro-
teinases, glomerular cells in culture have been demonstrated to
secrete a wide variety of biologically active factors. Table I lists
the main categories of these secretory products which may be
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Table 1. Biologically active substances produced in culture of whole glomerular cells*
Extracellular matrix constituents (9, 36, 47) ND (9, 36, 52) (9, 36)
Neutral proteinases ND ND (65, 117) ND
Cytokines ND ND (72, 73, 76, 78, 128) ND
Coagulation factors ND (18, 85) ND ND
Anti-thrombogenesis factors 129 (85) ND ND
Heparan—like substances ND ND ND (40)
Ficosanoids (7, 9, 93, 94, 96, 97) ND (7,9,95, III) (7, 9, 74, 95)
Platelet activating factors (103, 106, 107) ND (106, 107) ND
Reactive oxygen metabolites (112, 113) ND (III, 123) ND
* References for positive evidence of substance production are given in parenthesis, ND indicates no data available.
relevant to the glomerular inflammatory process in vivo. Just as
with matrix constituents and proteinases, it is likely that these
substances are key regulatory factors in the physiological
maintenance of glomerular ultrafiltration and the microvascular
circulation. In response to injury, the nonregulated production
of these agents may be responsible for significant structural and
functional glomerular alterations. In the process of tissue re-
pair, inadequately controlled secretion of products may in fact
lead to irreversible glomerular damage. More complete infor-
mation about the control mechanisms governing secretion and
action is required for the development of newer strategies to
interfere with these detrimental effects.
Gytokines
Cytokines are locally active polypeptide mediators which are
secreted by many cells. They are capable of modulating the
growth and biosynthetic activities of target cells in the imme-
diate environment. For example, interleukin 1 (IL-i) represents
a family of cytokines that are produced by several cell types,
including monocyte/macrophages, epidermal keratinocytes,
vascular endothelial cells, and glomerular mesangial cells
[70—73], In addition to a central action as an immunomodulatory
factor for T-cell activation, IL-l is a major mediator of the
inflammatory process [70, 71]. The major pro-inflammatory
effects of IL-i include induction of potymorphonuclear
ieukocyte chemotaxis, stimulation of target cell proliferation,
release of eicosanoids, enhancement of collagen synthesis and
stimulation of collagenase secretion [70, 71]. As discussed,
monocyte/macrophage IL-I was found to be a significant pro-
liferative stimulant for mesangial and endothelial cells [36, 39,
751. IL-i derived from mesangial cells was found to act as
co-mitogen for 1-cells, a property which was used to assay the
activity of this cytokine [72]. Moreover, mesangial cell IL-l was
found to possess intrinsic activity as an endogenous pyrogen
and to act as an autostimulatory mesangial cell growth factor
[73, 761. It is conceivable that an augmented release of the
mesangial cell IL-i may be an important determinant of the
hypercellularity commonly seen in glomerular inflammation.
An additional cytokine with extensive growth stimulatory
activity for many mesenchymal cell types is the platelet—
derived growth factor (PDGF) [77]. PDGF has been found to
induce responsiveness to the mitogenic effects of IL-i by
cultured mesangial cells [39]. Additionally, recent observations
have indicated that mesangial cells secrete a PDGF-like sub-
stance [78]. This finding appears analogous to previous reports
demonstrating that PDGF is produced by vascular endothelial
and smooth muscle cells [27, 79]. On the basis of these results,
it has been postulated that the striking proliferation of vascular
smooth muscle cells seen in atherosclerotic plaques may be
induced by the action of PDGF. This factor may be generated
by injured endothelial cells, recruited macrophages or platelets,
and possibly by the smooth muscle cells themselves [801. It is
presently unclear what mechanisms regulate the secretion and
action of these growth factors within the arterial wall, or by
inference, the glomerular capillary tuft. It is of obvious impor-
tance to further elucidate the roles of IL-i, PDGF, and related
cytokines in the evolution of the cellular proliferative events so
typical of glomerular inflammation.
As discussed, sensitive proliferation assays for defined pop-
ulations of glomerular cells and for other target cells (for
example, 1-cells and fibroblasts) are available. Using such
assays, the secretion and action of these cytokines can be
reliably and sensitively assayed in the conditioned media de-
rived from cultured glomerular cells, Once the various growth
modulatory factors are identified, the characterization of spe-
cific cytokinc receptors on the respective glomerular target cells
represents the next investigative goal. Related advances have
recently demonstrated the presence of a receptor for PDGF on
vascular smooth muscle cells, as well as a putative receptor for
IL-l on lymphocytes [81, 82]. Conceptually, the blockade of
glomerular cell growth factor receptors with biologically inac-
tive analogs or synthetic peptides may provide a targeted
mechanism for the specific inhibition of cellular proliferation.
Similarly, the specific inhibition of growth factor synthesis by
the glomerular cells may be applicable to the modulation of the
proliferative response seen in glomerutar inflammation.
At present, little information is available concerning the
release by glomerular cells of substances which, in analogy to
interferon [831, may inhibit proliferation. Recent work by
Castellot et al [40] has identified heparan—like substances pro-
duced by glomerular epithelial and endothelial cells which have
growth inhibitory actions on mesangial cells. It has been
speculated that related substances, such as heparan sulfate
proteoglycan, a normal constituent of the glomerular matrix,
may have antiproliferative effects on giomerular cells [40].
Local production of growth inhibitory factors may be of critical
importance for the control of an inflammatory response within
glomeruli. it is clear that much more investigative effort is
required in order to better understand this aspect of glomerular
growth regulation during inflammatory states.
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Activation of the coagulatton process
The coagulation process activation is an important interme-
diate mechanism in certain types of glomerular inflammation.
The elucidation of the contribution of glomerular cells to
coagulation and fibrinolysis is, therefore, relevant to an under-
standing of the glomerular response to injury, As holds for all
blood vessels, the glomerular endothelium has anti-thrombo-
genie properties. Platelet adherence is greatly reduced by the
negatively charged endothelial cell surface. While not demon-
strated for glomerular endothelial cells, analogy to non-glome-
rular endothelial cells would suggest that they may release
anti-aggregatory protacyclin $4]. Other endothelial prod ucts
may also regulate thromboresistance and fibrinolysis; these
include the protease inhibitor -2 macroglobulin and a tissue
plasminogen activator [85]. Endothelial cells contain several
coagulation factors and under certain conditions may actually
promote the coagulation process [85—871. For example,
endothelial cells in culture have been induced to express a
tissue factor—like procoagulant, which is a co-factor in the
initiation of the coagulation cascade [881. Of note, Il-I was
found to be a potent stimulant of endothelial cell procoagulant
activity [89, 90]. By analogy, it is likely that the glomerular
endothelial cells may play an active role in the local regulation
of coagulation and fibrinolysis, thereby affecting the glomerular
response to acute inflammatory injury. The methodology is in
place to test this hypothesis [18].
Eicosanoids
Eicosanoids are metabolites of arachidonic acid, a polyunsat-
urated long chain fatty acid. Produced by nearly all tissues.
these substances have an extremely wide range of biologic
action which contribute to the cellular response to injury [84,
91, 92]. Glomerular cells have been shown to produce multiple
eicosanoid products derived from the cyclooxygenase pathway
(PGE2, prostacylin, thromboxane A2) and the lipoxygenase
pathway (hydroxyeicosatetraenoic acids or HETE's, and
leukotrienes or LT's) [93—97]. Measurement of these metabo-
lites is widely performed by reverse phase high performance
liquid chromatography and/or radioimmunoassay. The speci-
ficity and validity of such determinations varies widely and
rigorous standardization of each assay is crucial. The induction
of glomerular eicosanoid secretion provides an array of potent
biochemical mediators which may greatly influence the inflam-
matory process. Particular attention has been given to throm-
boxane A2, PGE2 and lipoxygenase pathway products. Aug-
mented eicosanoid production was found from isolated
glomeruli obtained from animals with immune—mediated gb-
merulonephritis, diabetes mellitus, 5/6 nephrectomy, and
adriamycin glomerulonephropathy [98—102]. Although the
pathogenetic significance of increased eicosanoid production is
not well defined, these findings have led to the experimental use
of agents that either inhibit the production, or action, of certain
eicosanoids. This approach, which combines cell culture work
with directed in vivo experiments, may he expected to help
elucidate the contributions of locally synthesized eicosanoids to
the glomerular inflammatory response.
Platelet activating factor
Platelet activating factor (PAF) represents a group of bioac-
tive phospholipid metaholites that are closely linked to eico-
sanoid production. PAF mediates a number of pathophysiobogic
responses from a wide variety of target cells. Many cell types
produce PAF, including neutrophils, macrophages, platelets
and vascular endothelial cells 1103—105]. Isolated glomeruli and
cultured mesangial cells have been found to generate PAF [106,
107]. Since PAF is recognized to be a potent mediator of the
inflammatory process, it is reasonable to assume that it will
emerge as an important effector substance in the glomerular
response to injury. PAF released by injured vascular
endothelial cells was found to induce vascular smooth muscle
cell constriction and may also affect recruitment of platelets and
leukocytes to sites of endothelial injury [103]. Moreover, PAF
increases vascular permeability [1081. Presumably the local
generation of PAF by glomerular cells may further augment
glomerular injury and explain some of the characteristic func-
tional alterations. Measurements of PAF frequently utilize a
rather cumbersome platelet aggregation assay [107, 109]. PAF
may also be identified and quantitated by reverse phase HPLC
or thin layer chromatography with equivalent degrees of sensi-
tivity. Thus, current technology allows one to effectively study
the influence of PAF on the biology of defined populations of
glomerular cells. The availability of specific inhibitors of PAF
synthesis may provide additional insights into the mechanisms
of action of this important inflammatory mediator [103, 106,
110].
Reactive oxygen metuholiles
Finally, reactive oxygen metaholites are produced by glomer-
ular cells in response to a number of stimuli [111—114]. The most
significant of these are 02 and H707, which are readily
detected by determining the reduction of ferricytochrome c and
by fluoresence assay with scopoletin [111, 114].
Glomerular cell response to inflammatory stimuli
As outlined in the previous sections, increased proliferation
and altered biosynthetic activities represent the main reaction
patterns of glomerular cells to inflammatory stimuli. As several
examples of such stimulatory effects have been discussed
above, this section will he restricted to summarizing the avail-
able evidence in this area. The growth stimulatory actions of
macrophage and mesangial cell IL-I have been alluded to
above. PDGF is required for the in vitro proliferation of
glomerular endothelial cells [18]; the proliferation of visceral
epithelial cells was found to be augmented by the leukotrienes
LTC 4 and LTD 4 [115].
Accumulation of mesangial matrix represents a hallmark of
progressive gbomerular disease 112. 36]. Macrophage IL-I re-
portedly increases glomerular cell synthesis of collagen [36].
Prolonged cultures of mesangial cells in medium containing high
concentrations of serum revealed the formation of macroscopic
modules or hilbocks [52]. These macroscopic accumulations
were found to consist of large masses of matrix constituents,
including fibronectin and collagen types I, III, IV and V. The
precise matrix synthetic simulant responsible for these alter-
ations remains to be identified. Since matrix composition may
affect cell growth [10, 1161, it is possible that gbomerular cell
behavior may he modulated by factors that change basement
membrane or mesangial matrix. These hypotheses are directly
testable with glomerular cell culture.
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Recent findings by Martin et al [117] have shown that
macrophage IL-I stimulates the secretion by mesangial cells of
a type IV collagenase which degrades glomerular basement
membrane. It remains to be determined whether this additional
action of IL-I component of a multit'aceted mesangial cell
response to this pro-inflammatory cytokine.
Production of eieosanoids by glomerular cells has been found
to be mediated by a number of inflammatory factors. Eico-
sanoid secretion by mesangial cells is stimulated by IL-i [118],
PAF [119], hydrogen peroxide [120], terminal complement
components [121], and opsonized zymosan [111]. Incubation of
visceral epithelial cells with terminal complement components
also stimulated eicosanoid release [122]. Stimulation of reactive
oxygen species release by mesangial cells was found to be a
response to terminal complement components, opsonized
zymosan, and preformed immune complexes [III, 114, 123]. To
date, immune complexes have not been found to exert any
other appreciable effects on glomerular cell behavior in culture.
In this regard, it is noteworthy that immune complexes failed to
elicit proliferative or cytotoxic effects on vascular endothelial
cells [124].
Camussi et al [125], recently studied the effects of incubation
of visceral epithelial cells with antibodies directed against the
glycoproteins contained within the coated pits of these cells.
After formation of clusters of immune complexes, redistribu-
tion, capping, and subsequent shedding were observed, it
remains to be seen whether the processing of such cell
surface—associated immune complexes is associated with
changes in cell behavior.
A number of alterations of visceral epithelial cells have been
induced by exposure to toxins. For example, puromycin
aminonucleoside induced changes in the turnover and distribu-
tion of the polyanionic heparan sulfate proteoglycan and in cell
morphology [6, 7, 57, 1261. Mercuric chloride was found to
stimulate PGE2 secretion by cpithelial cells [127].
Summary
In this paper, we have attempted to provide an overview of
the methods and findings of a large number of investigators who
have dealt with an analysis of the glomerular inflammatory
response using tissue culture techniques. These observations
represent only a beginning. With the growing interest in this
aspect of kidney disease, it is to anticipated that many further
advancements in the understanding of the cell biology of the
glornerulus are forthcoming. The translation of this fundamental
information into new diagnostic and therapeutic modalities is an
exciting challenge to investigative nephrology.
Reprint requests to D.H. Lovett. Division of Nephrology, RM / I,
University of Washington, Seattle, Washington 98/95, U.S.A.
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